Interim Results from the Phase 1B and Phase 2 TORREY Open-label Extension Study of Seralutinib in Pulmonary Arterial Hypertension (PAH)

H Ghofrani, S Sahay, P Escribano-Subias, R Zolty, J Kingrey, B Penn, I Sobol, N Sood, R Benza, R Channick, K Chin, R Frantz, A Hemnes, L Howard, V McLaughlin, J Vachiéry, R Zamanian, M Cravets, R Roscigno, D Mottola, E Parsley, R Aranda, L Zisman, O Sitbon · Pneumologie · 2025 · Heft S 01 S 01 · S. S35-S36